A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of BA058 Administered Via a Coated Transdermal Microarray Delivery System (BA058 Transdermal) in Healthy Postmenopausal Women With Osteoporosis

Trial Profile

A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of BA058 Administered Via a Coated Transdermal Microarray Delivery System (BA058 Transdermal) in Healthy Postmenopausal Women With Osteoporosis

Completed
Phase of Trial: Phase II

Latest Information Update: 21 Dec 2016

At a glance

  • Drugs Abaloparatide (Primary) ; Abaloparatide (Primary)
  • Indications Postmenopausal osteoporosis
  • Focus Proof of concept; Therapeutic Use
  • Sponsors Radius Health Inc.
  • Most Recent Events

    • 19 Sep 2016 Results published in the Radius Health Inc Media Release
    • 19 Sep 2016 Results from this trial presented at the American Society for Bone and Mineral Research (ASBMR) 2016 Annual Meeting, according to a Radius Health Inc media release.
    • 03 Mar 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top